共 196 条
[1]
Nutt JG(2005)Diagnosis and initial management of Parkinson’s disease N Engl J Med 353 1021-1027
[2]
Wooten GF(2011)The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration Brain 134 3146-3166
[3]
Cummings JL(2008)Parkinson’s disease: clinical features and diagnosis J Neurol Neurosurg Psychiatry 79 368-376
[4]
Henchcliffe C(2003)Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders Mov Disord Off J Mov Disord Soc 18 467-486
[5]
Schaier S(1999)Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism Eur J Nucl Med 26 171-182
[6]
Simuni T(2001)An introduction to PET and SPECT neuroreceptor quantification models J Nucl Med 42 755-763
[7]
Waxman A(2010)In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with 18F-AV-133 J Nucl Med 51 223-228
[8]
Kemp P(2010)Whole-body biodistribution and radiation dosimetry of 18F-FP-(+)-DTBZ (18F-AV-133): a novel vesicular monoamine transporter 2 imaging agent J Nucl Med 51 1480-1485
[9]
Jankovic J(2009)Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study Brain 132 1376-1385
[10]
Litvan I(2009)Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson’s disease and healthy controls Eur J Nucl Med Mol Imaging 36 454-462